| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |